Stock market today: Wall Street drifts again ahead of Fed decision on rates
Published Mon, 01 Jul 2024 13:44:28 GMT
EU urges Serbia and Kosovo to respect their pledges after a meeting of leaders ends in acrimony
Published Mon, 01 Jul 2024 13:44:28 GMT
Unlicensed New York City acupuncturist charged after patient’s lungs collapsed, prosecutors say
Published Mon, 01 Jul 2024 13:44:28 GMT
Health Canada recalls CUPKIN stainless steel cups for kids due to potential lead exposure
Published Mon, 01 Jul 2024 13:44:28 GMT
Sponsor an ocean? Tiny island nation of Niue has a novel plan to protect its slice of the Pacific
Published Mon, 01 Jul 2024 13:44:28 GMT
A mayor in South Sudan was caught on video slapping a female street vendor. He has since been sacked
Published Mon, 01 Jul 2024 13:44:28 GMT
Spain allows Catalan, Basque and Galician languages in Parliament. EU ponders use in Brussels
Published Mon, 01 Jul 2024 13:44:28 GMT
Boy, 15, shot and wounded on Far South Side
Published Mon, 01 Jul 2024 13:44:28 GMT
Benches clear late in White Sox win over Nationals
Published Mon, 01 Jul 2024 13:44:28 GMT
UAW president vows more strikes if no progress by noon Friday
Published Mon, 01 Jul 2024 13:44:28 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says